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 INTRODUCTION
Antibiotic	 therapy	 is	 nowadays	 experiencing	
major	 threats	 and	 antibiotic	 resistance	 of	
microorganisms	 to	 various	 pharmaceutical	
requires	 intensive	 research	 for	 an	 alternative	
solution.	Although	it	is	known	for	a	long	time	that	
ions	 of	 metals	 (Ag,	 Cu,	 Zn,	 Sr	 and	 others)	 have	
antimicrobial	 properties,	 they	 have	 remained	 in	
obscurity	in	the	heyday	of	antibiotics.
Hydroxyquinolines	 alone	 or	 complexed	
with	 various	 metal	 ions	 have	 demonstrated	
the	 ability	 to	 inhibit	 in	 vitro	 growth	 of	 various	
microorganisms,	 in	 particular	 bacteria	 and	
fungi,	and	the	mechanism	is	represented	by	high	
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Abstract
The	preparations	based	on	hydroxyquinoline,	 in	various	combinations,	are	used	 in	medicine,	being	shown	
to	have	an	inhibitory	effect	against	bacteria,	molds,	fungi,	parasites,	and	viruses,	but	also	having	other	beneficial	
effects	mentioned	in	other	medical	conditions	(anti-cancer,	anti-degenerative,	anti-inflammatory).		
In	vitro	susceptibility	testing	of	microorganisms:	bacteria	(Gram	positive	and	Gram	negative),	yeast	(Candida 
spp.,)	and	unicellular	algae	(Prototheca	spp.)	at	the	preparations	based	on	hydroxyquinoline	(HQ)	and	its	cupric	
derivatives	deposited	on	hydroxyapatite	(HAP).
There	were	tested	microbial	strains	of	the	following	genera:	Escherichia,	Staphylococcus,	Micrococcus,	Bacillus,	
Candida,	 and	 Prototheca.	 The	 tested	 products	 (developed	 in	 the	 Laboratory	 for	 Nanobiomaterials	 Synthesis,	
Center	of	Physical	Chemistry,	Faculty	of	Chemistry	and	Chemical	Engineering,	UBB	Cluj-Napoca)	were	developed	
in	 three	 versions:	 1)	 HQ–Cu2+–HAP
1
;	 2)	 HQ–Cu2+–HAP
2
;	 and	 3)	 NHQ–Cu2+–HAP
2
,	 where	 NHQ	 stands	 for	 nitro	
hydroxyquinoline.	Determination	of	the	inhibitory	effect	was	conducted	by	diffusion	technique	in	Mueller-Hinton	
agar	(MHA),	according	to	CLSI	2013	standards,	with	necessary	adaptations	for	testing	of	products	made	in	the	form	
of	suspensions.	Following	 interpretation,	 it	was	 found	 that	 the	 inhibition	zones,	arising	 from	the	antimicrobial	
effect	of	the	tested	products	showed	variability	in	size,	depending	on	the	test	product	and	the	microbial	strain:	
Escherichia coli	(8-10	mm),	Staphylococcus	sp.	(17.6	-	23.2	mm),	Micrococcus	spp.	(24.4	-	27.6	mm),	Bacillus	spp.	
(14.0	-	16.0	mm),	Candida	spp.	(20.4	-	25.2	mm),	Prototheca	spp.	(20.8	-	30.0	mm).	From	the	three	tested	products,	
the	best	efficacy	was	found	at	the	product	no.	3	(NHQ	–	Cu2+	–	HAP
2
),	followed	by	no.	1	(HQ–	Cu2+–HAP
1
)	and	no.	2	
(HQ–Cu2+–HAP
2
).
The	inhibitory	effect	was	bactericidal,	manifested	more	intensively	against	Gram-positive	bacteria,	yeasts,	and	
prototheca.	Such	products,	prepared	in	the	form	of	suspensions,	may	have	practical	application	in	the	prevention	
and	treatment	of	skin	or	hooves	disorders.	No	resistance	phenomena	are	recorded.
Keywords: copper, hydroxyapatite, hydroxyquinoline, microorganisms, sensitivity.
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lipophilicity	 which	 penetrates	 the	 membranes	
of	 the	microbial	cells	by	binding	to	metal	 ions	of	
various	enzymes.	In	such	circumstances,	a	rupture	
of	 microbial	 cell	 walls	 and	 cell	 lysis	 occurs.	 In	
addition	 to	 this	 mechanism	 anti-inflammatory	
activity	 is	 revealed,	 a	 property	useful	 in	 treating	
infectious	diseases	(Kim	et al,	2005).	An	important	
aspect	 to	be	underlined	 is	 the	 fact	 that	 for	 these	
products	no	resistance	phenomena	as	 frequently	
occurs	 to	 antibiotics	 is	 observed.	 It	 underlines	
the	 importance	 of	 copper	 (Cu2+)	 considered	 as	
a	 metal	 with	 multiple	 meanings	 (Scăeţeanu	 and	
Pele,	 2013),	 its	 antibacterial	 properties	 being	
highlighted	in	literature	(Faúndez	et al.,	2004).
8	 Hydroxyquinoline	 (8-HQ)	 is	 an	 organic	
compound	 with	 chemical	 formula	 C
9
H
7
NO,	
molecular	weight	of	145.158	Da,	and	melting	point	
of	75ºC.	It	is	a	quinoline	derivative	of	a	heterocyclic	
ring,	by	placing	an	OH	group	on	the	carbon	8,	which	
is	8-hydroxyquinoline	(8HQ).	It	is	a	small	molecule,	
flat	(planar	small	molecule)	with	lipophilic	effect	
and	 metal	 chelating	 ability.	 This	 substance	 has	
the	appearance	of	an	amorphous	powder,	a	bright	
yellow	appearance,	soluble	in	alcohol,	acetic	acid,	
acetone,	 chloroform,	 benzene,	 ether,	 aqueous	
mineral	acids	and	almost	insoluble	in	water.	8-HQ	
was	 used	 in	 agriculture	 having	 insecticidal	 and	
preservative	 effect	 for	 textiles,	 wood,	 and	 paper	
industry,	 and	 in	 medicine	 for	 its	 antibacterial,	
antifungal,	 antiviral,	 anti-inflammatory	 and	
neuroprotective	 outcome	 (Anjaneyulu	 et al.,	
1982;	 Short	 et al.,	 2006;	 Prachayasittikul	 et al.,	
2013;	Al-Busafi	et al.,	 2014).	 8-HQ	 antimicrobial	
activity	is	more	intense	in	preparations	with	metal	
complexes	(Kim	et al.,	1998;	Srisung	et al.,	2013;	
Danistean	et al.,	2016).	
In	this	paper,	we	aimed	to	investigate	the	anti-
microbial	effect	of	8-HQ	and	its	cooper	derivatives,	
deposited	 on	 hydroxyapatite	 (HAP),	 prepared	 in	
three	suspension	versions.	Compared	to	the	anti-
microbial	activity	of	8-HQ	and	cooper	derivatives,	
we	 tested	 whether	 added	 HAP	 is	 conferring	 a	
strong	dispersion	and	penetration,	 ensuring	bet-
ter	bioactivity	of	the	preparations	designed.
MATERIALS AND METHODS
Data on tested products.	The	products	were	
developed	in	the	Laboratory	for	Nanobiomaterials	
Synthesis,	 Center	 of	 Physical	 Chemistry,	 Faculty	
of	 Chemistry	 and	 Chemical	 Engineering,	 UBB	
Cluj-Napoca,	 prepared	 in	 three	 versions:	 1)	 HQ	
(4.1%)	 –	 Cu2+	 (3.5%)	 -	 HAP
1
	 (presynthesized);	
2)	HQ	(4.5%)	 -	Cu2+	 (8.2%)	 -	HAP
2
	 (produced	by	
synthesis);	 and	 3)	 NHQ	 (5.1%)	 -	 Cu2+	 (8.1%)	 -	
HAP
2
	 (produced	 by	 synthesis),	 where	 are	 NHQ	
stands	for	nitro-hydroxyquinoline.	
The	 stoichiometric	 hydroxyapatite	 (HAP
1
)	
powder	was	obtained	at	a	molar	ratio	Ca/P	of	1.67	
by	 a	 chemical	 precipitation	 method	 [11,	 18,	 29,	
30,	 31].	 The	 already	 synthesized	 HAP1	 powder	
was	used	for	the	adsorption	of	HQ,	Cu2+	ions,	and	
of	 their	 HQ	 and	 Cu2+	 self-assemblies.	 The	 HAP
2
 
powder	 was	 directly	 synthesized	 during	 the	
preparation	of	self-assemblies	of	either	HQ	or	NHQ	
with	Cu2+	ions.	As	a	consequence,	the	HAP
2
	can	be	
doped	 with	 Cu2+,	 at	 least	 to	 a	 small	 percentage.	
This	aspect	will	be	investigated	in	future	studies,	
to	 evaluate	 the	 efficacy	 of	 HQ	 and	 NHQ,	 in	 the	
presence	of	Cu2+	 ions,	against	various	pathogens,	
using	HAP	as	carriers	for	their	local	delivery.	
The	 evaluation	 of	 the	 antimicrobial	 effect	
was	 performed	 in	 Microbiology	 Laboratory	 of	
the	 Faculty	 of	Veterinary	Medicine,	University	 of	
Agricultural	 Sciences	and	Veterinary	Medicine	of	
Cluj-Napoca.	The	products	had	a	greenish/bluish	
color	due	to	copper,	pH	was	6.0	to	6.4	and	liquid	
consistency	 in	 the	 form	 of	 suspensions	 which	
settle,	but	when	stirred	would	mix	evenly.
Data on microbial strains.	Microbial	strains	
that	were	tested	are	part	of	the	following	groups,	
respectively	 genera:	 Gram-negative	 bacteria	
(Escherichia,	 Salmonella);	 Gram-positive	 bacteria	
(Staphylococcus,	 Micrococcus,	 Bacillus);	 yeast	
(Candida)	and	unicellular	algae	(Prototheca).	The	
selected	strains	were	cultured	for	24	h	in	glucose	
broth	–	obtaining	the	young	cultures.	The	strains	
used	 in	the	test	were	 isolated	 from	clinical	cases	
or	 from	 the	 environment	 and	 are	 part	 of	 the	
collection	of	Microbiology	department,	Faculty	of	
Veterinary	 Medicine	 of	 Cluj-Napoca.	 In	 addition,	
international	 reference	 ATCC	 (American	 Type	
Culture	Collection)	strains	were	also	used.
Working protocol.	Microbial	strains	were	in-
oculated	on	glucose	culture	media	(nutrient	broth	
and	 agar)	 (TM	 MEDIA	 TITAN	 BIOTECH,	 India),	
incubated	at	37°C	in	aerobic	conditions	for	18-24	
hours	(bacteria)	and	48-72	hours	(yeast	and	uni-
cellular	 algae).	 The	 inhibitory	 effect	 was	 tested	
using	antibiotic	susceptibility	by	nutrient	agar	dif-
fusion	method	according	 to	CLSI	standards,	with	
the	necessary	adaptations	for	testing	products	in	
the	 form	of	suspensions.	 In	this	regard,	 the	MHA	
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was	melted	on	a	water	bath	and	poured	into	Petri	
dishes	with	a	diameter	of	90	mm	in	an	amount	of	
25	ml	to	form	a	uniform	layer	with	a	thickness	of	
3	mm.	
The	 inoculation	 was	 performed	 by	 flooding,	
using	1	ml	of	suspension	of	the	strain	tested	with	
the	optical	density	0.5	on	McFarland	scale	for	bac-
teria	 and	1.0	 for	 fungi	 and	algae.	The	dispersion	
was	evenly	done	and	then	the	excess	fluid	was	re-
moved.	Once	 the	 surface	was	dried,	wells	with	a	
diameter	of	6	mm	were	cut	into	the	agar.	The	wells	
were	filled	with	2	to	20	μl/well	 for	each	product	
used	in	the	test,	according	to	the	protocol.	The	in-
oculated	plates	were	incubated	in	a	thermostat	at	
37°C	for	18-24	hours	for	bacteria	and	48-72	hours	
for	 yeasts	 and	unicellular	 algae.	The	plates	were	
evaluated	regarding	the	presence/absence	of	colo-
nies	development	around	the	wells.	When	the	in-
hibitory	effect	was	observed,	 the	diameter	of	the	
inhibition	 areas	 was	 measured;	 the	 value	 being	
expressed	in	millimeters.
After	this	time	the	plates	were	read,	assessing	
the	presence	or	absence	of	cultural	development	
around	 the	 wells.	 In	 the	 case	 of	 an	 inhibitory	
effect,	 the	 diameter	 of	 the	 inhibition	 zones	 has	
been	 measured,	 the	 value	 read	 being	 expressed	
in	millimeters.	The	diffusion	method	used	by	us,	
has	the	advantage	that	in	the	absence	of	standard	
discs,	can	test	liquids	or	suspensions,	by	practicing	
wells	in	nutrient	agar,	and	filling	being	made	with	
calibrated	pipettes.
Preliminary	 tests	 were	 performed	 against	
various	microbial	strains	using	different	amounts	
of	 products	 (2μl,	 5μl,	 10μl	 and	 20μl/well)	 in	
order	 to	 estimate	 the	 amount	 that	 causes	 the	
inhibitory	effect	against	diverse	microorganisms.	
Subsequently,	 25	 strains	 were	 tested,	 5	 of	 each	
microbial	 genus:	 Staphylococcus,	 Micrococcus,	
Bacillus,	Candida,	 and	Prototheca;	 4	 strains	 from	
the	collection	of	the	Microbiology	department	and	
a	reference	ATCC	strain	(except	for	micrococci).	
To	determine	whether	the	inhibitory	effect	is	
bactericidal	or	bacteriostatic,	 from	the	 inhibition	
areas	 inoculations	 were	 performed	 in	 broth,	
followed	by	incubation	at	37°C	for	24	hours.
RESULTS AND DISCUSSIONS
1. The results according to the amount of 
products placed in the wells
Verification	made	with	increasing	amounts	of	
products	 (2μl,	 5μl,	 10μl,	 and	 20μl)	 revealed	 that	
the	inhibitory	effect	is	correlated	with	the	quantity	
deposited	 into	 the	wells	 and	 especially	with	 the	
group	of	tested	microorganisms.
For	Gram-negative	bacteria,	strains	of	Escheri-
chia coli	 and	 Salmonella	 spp.,	 none	 of	 the	 three	
products	 revealed	 inhibition	 areas,	 or	 they	were	
very	small,	with	narrow	zones	of	inhibition	of	8-10	
mm,	seen	in	some	E. coli	strains.
On	 the	 other	 hand,	 against	 Gram-positive	
bacteria	 (Staphylococcus aureus,	Bacillus cereus),	
yeasts	 (Candida albicans)	 and	 algae	 (Prototheca 
zopfii),	it	was	found	that	all	three	tested	products	
had	 a	 clear	 and	 intense	 inhibitory	 activity.	 The	
inhibitory	 effect	 is	 produced	 from	 2μl/well	 and	
increases	 in	 intensity	 as	 the	 amount	 of	 product	
deposited	in	the	wells	increases;	the	largest	zones	
of	inhibition	were	observed	for	20	μl/well. 2. The results for HQ products against the 
reference strains and the strains isolated from 
clinical cases and the environment
Since	 previous	 tests	 revealed	 that	 HQ-based	
products	exhibit	a	significant	 inhibitory	effect	on	
Gram-positive	strains	of	bacteria,	yeast,	and	algae,	
the	next	step	was	to	test	the	sensitivity	of	strains	
belonging	to	the	respective	groups.	The	wells	cut	
in	 the	 gel	 of	 nutrient	 agar	 plates	were	 arranged	
in	a	triangular	pattern,	and	in	the	central	well	of	
the	plate	was	placed,	as	a	control,	the	suspension	
of	hydroxyapatite	 (HAP).	The	amount	of	product	
deposited	in	the	wells	was	20	μl/well.
2.1. The result regarding the susceptibility 
of the genus Staphylococcus
The	 strain	 of	 Staphylococcus aureus ATCC 
6538	P	and	4	other	strains	isolated	from	dairy	cow	
mastitis	were	 tested.	The	 strains	were	 identified	
based	 on	morphological	 characters	 (cocci,	 Gram	
positive	 stain,	 grape	 shaped),	 catalase-positive,	
mannitol-positive.	All	strains	produced	hemolysis	
on	blood	agar.	The	results	are	summarized	in	Tab.	
1.
By	analyzing	the	data	in	Tab.	1	it	can	be	seen	
that	 HQ	 based	 products	 have	 a	 good	 inhibitory	
effect	on	Staphylococcus.	
In	 the	case	of	product	1	(HQ-Cu2+-HAP
1
),	 the	
inhibition	areas	ranged	between	20	to	22	mm,	the	
constant	size	of	diameter	for	4	strains	was	22	mm,	
and	 the	 fifth	was	 20	mm;	 the	 average	 inhibition	
size	was	21.6	mm.
For	 product	 2	 (HQ-Cu2+-HAP
2
)	 the	 inhibition	
areas	 were	 smaller,	 between	 16-18	 mm	 and	 is	
also	noted	that	the	size	for	4	strains	was	18	mm	in	
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diameter	and	for	the	other	was	16	mm;	average	=	
17.6	mm.
For	 product	 3	 (NHQ-Cu2+-HAP
2
)	 inhibition	
areas	 were	 larger,	 between	 20-24	 mm,	 with	 24	
mm	for	4	strains	and	20	mm	for	the	fifth;	average	
=	23.2	mm.
The	 negative	 control	 (HAP)	 have	 not	
demonstrated	inhibition	activity.
The	 examination	 to	 determine	 whether	 the	
inhibitory	effect	was	bactericidal	or	bacteriostatic	
showed	that	all	three	products	had	a	bactericidal	
effect.	 In	 the	 inhibition	 area	 of	 the	 product	 1,	
there	is	a	circular	opaque	area,	which	is	due	to	the	
precipitation	of	components	from	the	environment.	
No	microorganisms	were	found	in	those	areas,	the	
control	 inoculation	 being	 sterile.	 Aspects	 of	 the	
inhibitory	 effect	 against	 Staphylococcus	 tested	
strains	are	presented	in	the	Figures	1	(a	and	b).
2.2. The result regarding the susceptibility 
of the genus Micrococcus
There	 were	 tested	 five	 strains	 of	 M. luteus 
(lysodeikticus),	from	the	collection	of	Microbiology	
Department,	 isolated	 from	 different	 secretions	
(nasal,	 conjunctival,	 auricular,	 milk).	 Samples	
were	 inoculated	 into	 broth	 and	 spread	 on	 agar	
and	blood	agar	plates.	The	strains	were	identified	
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Fig. 1.	Inhibition	zones	found	in	strains	of	the	genus	Staphylococcus
Tab. 1.	The	susceptibility	of	genus	Staphylococcus
No
Tested	strains
Products	with	HQ
(inhibition	areas/mm) HAP	
(control)
Effect
1
HQ-Cu2+-HAP1
2
HQ-Cu2+ -HAP2 3NHQ-	Cu2+- HAP2
1
Staphylococcus aureus
ATCC	6538P
22 18 24 0 bactericidal
2 Staphylococcus spp., 2 22 18 24 0 bactericidal
3 Staphylococcus spp., 3 22 18 22 0 bactericidal
4 Staphylococcus spp., 4 22 18 24 0 bactericidal
5 Staphylococcus spp., 5 20 16 22 0 bactericidal
Average	of	the	
inhibition	area	
21.6 17.6 23.2 0
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based	on	morphological	characters	(cocci,	Gram-
positive	staining,	diplo/tetrad	grouping),	catalase-
positive,	 mannitol-negative.	 All	 strains	 were	
pigmented,	with	a	bright	yellow	pigment.	On	blood	
agar,	 narrow	 areas	 of	 hemolysis	 are	 observed	 to	
some	of	the	strains.	
The	inhibition	areas	have	been	large	and	well	
defined.	 Around	 the	well	 containing	 the	 product	
1,	there	is	a	circular	area	of	opacification,	as	also	
observed	 in	 staphylococci.	 On	 inspection	 was	
found	 that	 germs	 were	 not	 present	 because	 the	
inoculated	tubes	remained	sterile.	The	results	are	
summarized	in	Tab.	2.
Aspects	 of	 the	 inhibitory	 effect	 against	
Micrococcus tested	 strains	 are	 presented	 in	 the	
Figure	2	(a	+	b).
By	analyzing	the	data	in	Tab.	2	it	can	be	seen	
that	 HQ	 based	 products	 have	 a	 good	 inhibitory	
effect	on	Micrococcus	strains.
For	product	1	(HQ-Cu2+-HAP
1
),	 the	 inhibition	
areas	 ranged	 between	 20	 to	 30	 mm,	 with	 the	
following	 values:	 strain	 1	 (28	mm);	 strain	 2	 (20	
mm),	 strain	 3	 (30	 mm),	 strain	 4	 (22	 mm)	 and	
strain	5	(26	mm);	the	average	inhibition	size	was	
25.2	mm.
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Fig. 2.	Inhibition	zones	found	for	strains	of	the	Micrococcus	genus
Tab. 2.	The	susceptibility	of	genus	Micrococcus
No
Tested	strains
Products	with	HQ
(inhibition	areas/mm) HAP	
(control)
Effect
1
HQ-Cu2+-HAP
1
2
HQ-Cu2+-HAP
2
3
NHQ-Cu2+-HAP
2
1
Micrococcus luteus
(lysodeikticus) 28 20 30 0 bactericidal
2 Micrococcus spp. 2 20 16 24 0 bactericidal
3 Micrococcus spp. 3 30 20 32 0 bactericidal
4 Micrococcus spp. 4 22 18 24 0 bactericidal
5 Micrococcus spp. 5 26 24 28 0 bactericidal
Average	of	the	
inhibition	area
25.2 19.6 27.6
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For	 product	 2	 (HQ-Cu2+-HAP
2
)	 the	 inhibition	
areas	 were	 smaller,	 between	 16-24	 mm:	 strain	
1	 (20	mm),	 strain	2	 (16	mm),	 strain	3	 (20	mm),	
strain	4	(18	mm)	and	strain	5	(24	mm);	average	=	
19.6	mm.
For	 product	 3	 (NHQ-Cu2+-HAP
2
)	 inhibition	
areas	were	 the	 largest	 -	 24-32	mm:	 strain	 1	 (30	
mm),	strain	2	 (24	mm),	strain	3	 (32	mm),	strain	
4	(24	mm)	and	strain	5	(28	mm);	average	=	27.6	
mm.
2.3. The result regarding the susceptibility 
of the genus Bacillus
We	tested	a	reference	strain	of	Bacillus cereus 
ATCC	14579,	and	4	strains	from	the	Microbiology	
Department	 collection,	 isolated	 from	 various	
sources,	 mainly	 from	 mastitic	 milk.	 The	 strains	
were	 inoculated	 on	 common	 culture	media,	 and	
onto	an	egg-based	medium	to	highlight	the	ability	
to	produce	lecithinase.	
The	strains	showed	typical	morphological	and	
cultural	characters	for	Bacillus cereus.	The	results	
are	summarized	in	Tab.	3.
By	analyzing	the	data	in	Tab.	3	it	can	be	seen	
that	 HQ	 based	 products	 have	 a	 good	 inhibitory	
effect	on	Bacillus cereus strains. 
To	the	product	1	(HQ-Cu2+-HAP
1
),	the	inhibition	
areas	 ranged	 between	 12	 to	 20	 mm,	 with	 the	
following	values:	reference	strain	(20	mm);	strain	
2	 (18	mm),	 strain	 3	 (12	mm),	 strain	 4	 (14	mm)	
and	the	strain	5	(14	mm);	 the	average	 inhibition	
size	was	15.6	mm.	It	can	notice	the	existence	of	a	
circular	area	of	opacity,	but	the	germs	are	absent	
because	the	inoculation	in	control	tubes	(glucose	
broth)	was	sterile.
For	 product	 2	 (HQ-Cu2+-HAP
2
)	 the	 inhibition	
areas	 were	 smaller,	 between	 10-20	 mm:	 strain	
1	 (20	mm),	 strain	2	 (16	mm),	 strain	3	 (12	mm),	
strain	4	(12	mm)	and	strain	5	(10	mm);	average	=	
14.0	mm.
For	 product	 3	 (NHQ-Cu2+-HAP
2
)	 inhibition	
zones	 were	 larger,	 ranging	 between	 14	 and	 24	
mm:	strain	1	(24	mm),	strain	2	(22	mm),	strain	3	
(14	mm),	strain	4	(14	mm)	and	strain	5	(16	mm);	
average	=	18.0	mm.
Aspects	 of	 the	 inhibitory	 effect	 against	 B. 
cereus tested	strains	are	presented	in	the	fig.	3	(a	
+	b).
2.4. The result regarding the susceptibility 
of the genus Candida
We	 tested	 one	 reference	 strain	 (ATCC	
90028)	 and	 4	 strains	 available	 in	 the	 collection	
of	 Microbiology	 Department,	 being	 isolated	
from	 various	 sources	 (oral	 cavity,	 mastitic	 milk,	
skin	 lesions).	 Inoculation	 was	 initially	 done	 in	
glucose	 broth,	 followed	 by	 passage	 on	 glucose	
agar	and	Sabouraud	medium.	Upon	bacterioscopic	
examination,	 all	 tested	 strains	 showed	 typical	
morphology:	ovoid	shape,	3/5-6	μm	in	size,	with	
characteristic	burgeoning	appearance.	The	results	
are	summarized	in	Tab.	4.
By	analyzing	the	data	in	Tab.	4	it	can	be	seen	
that	 HQ	 based	 products	 have	 a	 good	 inhibitory	
effect	 on	 genus	 Candida	 yeasts,	 even	 if	 they	
belonged	to	different	species.
RĂPUNTEAN	et al
Tab. 3.	The	susceptibility	of	Bacillus cereus	strains
No
Tested	strains
Products	with	HQ
(inhibition	areas/mm) HAP	
(control)
Effect
1
HQ	-	Cu2+-	HAP
1
2
HQ	-	Cu2+ -	HAP2 3NHQ	-	Cu2+- HAP2
1
Bacillus cereus
ATCC	14579
20 20 24 0 bactericidal
2 Bacillus cereus 2 18 16 22 0 bactericidal
3 Bacillus cereus 3 12 12 14 0 bactericidal
4 Bacillus cereus 4 14 12 14 0 bactericidal
5 Bacillus cereus 5 14 10 16 0 bactericidal
Average	of	the	
inhibition	area
15.6 14.0 18.0
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For	product	1	(HQ-Cu2+-HAP
1
),	 the	 inhibition	
areas	 ranged	 between	 22	 to	 28	 mm,	 with	 the	
following	 values:	 strain	 1	 (28	mm);	 strain	 2	 (22	
mm),	 strain	 3	 (24	 mm),	 strain	 4	 (22	 mm)	 and	
strain	5	(24	mm);	the	average	inhibition	size	was	
24.0	mm.
To	 the	 product	 2	 (HQ-Cu2+-HAP
2
),	 the	
inhibition	 areas	 ranged	 between	 18	 to	 26	 mm:	
strain	1	(26	mm),	strain	2	(18	mm),	strain	3	(20	
mm),	 strain	 4	 (18	 mm)	 and	 strain	 5	 (20	 mm);	
average	=	20.4	mm.	
For	 product	 3	 (NHQ-Cu2+-HAP
2
)	 inhibition	
zones	were	the	largest,	ranging	between	24	to	30	
mm:	strain	1	(30	mm),	strain	2	(24	mm),	strain	3	
(28	mm),	strain	4	(24	mm)	and	strain	5	(26	mm);	
average	=	26.4	mm.
It	can	be	shown	that	against	Candida	 strains	
a	 good	 inhibitory	 efficacy	 was	 recorded,	 the	
inhibition	 areas	 being	 large,	well	 delineated.	We	
note	 that	 in	 the	 case	 of	 some	 Candida	 strains,	
an	 opacity	 area	 is	 present	 around	 the	well	 with	
product	1,	but	without	the	presence	of	living	cell	
because	 the	 control	 inoculation	 appears	 to	 be	
Microscopical	Aspects	Concerning	the	Presence	snd	Distribution	of	Mitochondria	in	Ducts	from	Rat	Parotid	Gland
Tab. 4.	The	susceptibility	of	genus	Candida
No
Tested	strains
Products	with	HQ
(inhibition	areas/mm) HAP	
(control)
Effect
1
HQ	-	Cu2+-	HAP
1
2
HQ	-	Cu2+ -	HAP2 3NHQ	-	Cu2+- HAP2
1
Candida albicans 
ATCC	90028
28 26 30 0 fungicidal
2 Candida	kefyr 22 18 24 0 fungicidal
3 Candida	albicans	1 24 20 28 0 fungicidal
4 Candida	albicans	2 22 18 24 0 fungicidal
5 Candida	albicans	3 24 20 26 0 fungicidal
Average	of	the	
inhibition	area
24.0 20.4 26.4
 
Fig. 3.	Inhibition	areas	found	in	B. cereus	strains
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sterile.	Control	product	(HAP)	shows	no	inhibitory	
effect.	
Aspects	of	the	inhibitory	effect	against	Candida 
strains	are	presented	in	fig.	4	(a	+	b).
2.5. The result regarding the susceptibility 
of Prototheca strains
We	 tested	 a	 reference	 strain	 of	 Prototheca 
wickerhamii	 (ATCC	 16529)	 and	 4	 strains	 of	
Prototheca zopfii	 from	 the	 collection	 of	 the	
Microbiology	Department,	 isolated	 from	mastitic	
milk.	Cultivation	was	carried	out	on	glucose	culture	
media,	and	colonies	occurred	in	48-72	hours,	with	
characteristic	 features	 (3-4	mm	 diameter,	 white,	
matte,	slightly	lobed	edges,	granular	surface	with	
cauliflower	 appearance).	 When	 examining	 the	
wet	 smears	 in	Lugol	 solution,	 all	 strains	 showed	
typical	 morphology	 for	 Prototheca,	 round	 shape	
with	 dimensions	 of	 6-20	 μm	 for	 P. wickerhamii,	
and	ovoid	shape	with	20-30	μm	size	 for	P. zopfii,	
and	 with	 the	 presence	 of	 endospores,	 that	 is	 a	
characteristic	feature	for	this	algae.	The	results	are	
summarized	in	Tab.	5.
By	analyzing	the	data	in	Tab.	5	it	can	be	seen	
that	 HQ	 based	 products	 have	 a	 good	 inhibitory	
effect	on	Prototheca algae.	
For	product	1	(HQ-Cu2+-HAP
1
),	 the	 inhibition	
areas	ranged	between	26	to	34	mm,	the	constant	
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Tab. 5.	The	susceptibility	of	genus	Prototheca
No
Tested	strains
Products	with	HQ
(inhibition	areas/mm) HAP	
(control)
Effect
1
HQ-Cu2+-HAP
1
2
HQ-Cu2+-HAP
2
3
NHQ-Cu2+-HAP
2
1 Prototheca zopfii 1 26 20 30 0 algicidal
2 Prototheca zopfii 2 26 18 28 0 algicidal
3 Prototheca zopfii 3 26 18 28 0 algicidal
4 Prototheca zopfii 4 26 18 28 0 algicidal
5
P. wickerhamii
ATCC	16529
34 30 36 0 algicidal
Average	of	the	
inhibition	area
27.6 20.8 30.0
Fig. 4.	Inhibition	areas	found	for	strains	of	the	Candida	genus.
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size	of	diameter	for	4	strains	was	26	mm,	and	the	
fifth	was	 larger	 (34	mm);	 the	 average	 inhibition	
size	being	27.6	mm.
To	 the	 product	 2	 (HQ-Cu2+-HAP
2
),	 the	
inhibition	 areas	 ranged	 between	 18	 to	 30	 mm:	
is	 constant	 in	 size	 for	P. zopfii:	 strain	1	 (20	mm)	
and	strains	2,	3	and	4	(18	mm),	and	to	the	strain	P. 
wickerhamii	the	area	of	inhibition	was	higher	(30	
mm);	average	=	20.8	mm.	
For	 product	 3	 (NHQ-Cu2+-HAP
2
)	 inhibition	
zones	were	the	largest,	ranging	between	28	to	36	
mm.	For	P. zopfii:	strain	1	(30	mm),	strains	2,	3,	4	
(28	mm).	For	P. wickerhamii	 strain	the	 inhibition	
area	was	 larger	 (36	mm);	 the	 average	 inhibition	
size	 being	 30.0	 mm.	 Aspects	 regarding	 growth	
inhibition	 of	 Prototheca	 strains	 are	 shown	 in	
figure	5	(a	+	b).
Hydroxyquinoline-based	 preparations	 in	
combination	with	copper	pentahydrate	deposited	
on	 hydroxyapatite	 were	 tested	 in	 order	 to	
determine	the	ability	to	inhibit	the	in	vitro	growth	
of	some	bacterial	strains	(Gram	positive	and	Gram	
negative),	yeasts	and	unicellular	algae.
Initial	 testing	 carried	 out	 by	 distribution	 in	
the	wells	of	increasing	amounts	of	each	product	(2	
μl,	5μl,	10	μl	and	20	μl)	has	been	found	that	Gram	
negative	 bacteria	 (Escherichia coli,	 Salmonella 
typhimurium)	 proved	 to	 be	 less	 sensitive	 or	 not	
inhibited.	 Lower	 sensitivity	 of	 Gram-negative	
bacteria	 has	 been	 reported	 by	 other	 research	
specified	 in	 the	 investigated	 literature	 (Shen	
et al.,	 1999;	 Okide	 et al.,	 2000;	 Al-Busafi	 et al.,	
2014).	 Gram-positive	 bacteria	 were	 found	 to	 be	
more	 sensitive,	 inhibition	 zones	 were	 recorded	
for	 all	 of	 the	 products.	 The	 inhibitory	 effect	 is	
produced	 starting	 with	 2	 μl/well,	 and	 increases	
in	 intensity	 as	 the	 amount	 of	 product	 deposited	
in	the	wells	also	increases.	After	this	first	stage	of	
the	 investigations,	 it	 has	 been	 observed	 that	 the	
best	efficacy	has	product	no.	3	(NHQ-Cu2+-HAP
2
),	
and	 the	 amount	 that	 make	 the	 largest	 zones	 of	
inhibition	is	20μl/well.	We	believe	that	differences	
in	sensitivity	between	the	two	groups	of	bacteria	
is	probably	due	to	differences	 in	 the	structure	of	
the	 cell	 wall,	 which	 for	 Gram	 negative	 bacteria	
is	 thinner	 but	 more	 complex,	 and	 for	 the	 Gram	
positive	is	thicker,	but	structurally	much	simpler.
By	 analyzing	 the	 inhibitory	 effect	 induced	
by	 the	 tested	 products	 against	microbial	 strains,	
grouped	 by	 genre	 (Staphylococcus,	 Micrococcus,	
Bacillus,	 Candida	 and	 Prototheca),	 and	 taking	 as	
a	basis	 the	average	value	of	 the	diameters	of	 the	
inhibition	areas,	it	can	be	shown	that	the	growth	
of	all	the	strains	was	inhibited	(Tab.	6).
Depending	 on	 the	 average	 value	 of	 the	
diameters	 of	 the	 inhibition	 zones,	 of	 the	 strains	
placed	 in	 genres	 (horizontal	 columns),	 it	 can	 be	
seen	that	the	sensitivity	has	an	average	value	scale	
in	descending	order	as	 follow:	Prototheca	 (26.13	
mm),	 Micrococcus	 (24.13	 mm)	 Candida	 (23.60	
mm),	 Staphylococcus	 (20.80	 mm)	 and	 Bacillus 
(15.88	mm).
Microscopical	Aspects	Concerning	the	Presence	snd	Distribution	of	Mitochondria	in	Ducts	from	Rat	Parotid	Gland
Fig. 5.	Inhibition	zones	found	for	strains	of	the	Prototheca	genus.
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Depending	 on	 the	 average	 value	 of	 the	
diameters	 of	 the	 zones	 of	 inhibition	 induced	 by	
each	 of	 the	 three	 products	 (vertical	 columns)	
efficacy	 was	 framed	 in	 the	 following	 scale	 of	
values	 in	 descending	 order:	 the	 most	 intensive	
inhibitory	activity	was	recorded	to	the	product	no.	
3	 (NHQ-Cu2+-HAP
2
)	 (25.04	mm),	 followed	by	 the	
product	no.	1	 (HQ-Cu2+-HAP
1
)	 (22.8	mm)	and	by	
the	product	2	(HQ-Cu2+-HAP
2
)	(18.48	mm).
The	fact	that	8	HQ	have	good	efficacy	against	
Staphylococcus	strains	is	also	underlined	by	other	
authors.	 In	 a	 study	 performed	 on	 213	 strains	
of	 Staphylococcus	 strains,	 using	 an	 aqueous	
preparation	 containing	 0.5%	 hydroxyquinoline	
(AQ	 +)	 it	 was	 found	 that	 the	 preparation	 was	
shown	to	strongly	inhibit	the	growth	of	all	isolates	
with	a	median	MIC	of	0.25%	at	an	optimum	pH	of	
9.2.	It	is	also	mentioned	that	lowering	the	pH	to	7.5	
will	gave	a	4-fold	reduction	in	efficacy	and	at	pH	
5.5	 there	 is	an	approximately	8-fold	reduction	 in	
efficacy	(Short	et al.,	2006).	The	same	researchers	
show	 that	 MRSA	 strains	 as	 well	 as	 vancomycin-
intermediate	 strains	 are	 equally	 susceptible	 to	
AQ+	as	methicillin-susceptible	S. aureus.	The	TEM	
technique	 (Transmission	 Electron	 Microscopy)	
prove	 that	 AQ+	 actively	 disrupts	 the	 cell	 wall	
of	 S. aureus	 and	 therefore	 leading	 to	 cell	 lysis.	
Such	 results	 demonstrate	 that	 AQ+	 has	 strong	
antimicrobial	activity	and	is	possible	to	be	useful	
in	formulas	that	will	reduce	nasal	and	skin	carriage	
of	MRSA	(Short	et al.,	2006).		
The	 efficacy	 of	 8-HQ	 against	 S. aureus 
is	 dependent	 on	 the	 chelating	 ability,	 and	 is	
enhanced	 by	 the	 presence	 of	 copper	 (Pavolov	
et al.,	 2011).	 It	 is	noted	 that	 some	derivatives	of	
8-HQ	have	greatly	enhanced	antimicrobial	activity	
in	 the	 presence	 of	 copper	 (Rohde	 et al.,	 1976).	
Inhibitory	 effect	 was	 also	 found	 in	 intestinal	
bacteria,	 both	 aerobic	 (E. coli,	 Lactobacillus 
acidophilus,	 Lactobacillus casei,	 Bifidobacterium 
longum)	 and	 anaerobic	 (Clostridium difficile,	
Clostridium perfringens)	 (Jeon	 et al.,	 2009).	 It	
has	been	found	that	8-HQ	has	an	inhibiting	effect	
against	 Mycobacterium tuberculosis	 (Darby	 et	
Nathan,	 2010).	 Complexation	 of	 derivatives	 of	
8-HQ	 with	 Cu	 and	 Ni	 improves	 antimicrobial	
activity,	 as	 demonstrated	 for	 the	 Staphylococcus 
aureus,	Proteus vulgaris,	Pseudomonas aeruginosa 
and	 Klebsiella pneumoniae	 strains	 (Vashi	 et	
Sheth,	 2013).	 The	 inhibitory	 activity	 was	 also	
demonstrated	 for	 Mycoplasma	 and	 Ureaplasma 
strains,	 isolated	 from	 urinary	 tract	 infections	
(Bonissol	et al.,	1986).	
Regarding	 the	 mechanism	 of	 action,	 8-HQ	
and	 its	 derivatives	 are	 effective	 against	 Gram	
positive	 bacteria	 and	 less	 effective	 against	 Gram	
negative	(Shen	et al.,	1999;	Okidata	et al.,	2000).	
It	 is	 also	 found	 that	 8-HQ	 has	 high	 lipophilicity	
and	has	the	ability	to	penetrate	the	bacterial	cell	
membranes,	 possibly	 by	 binding	 the	 metal	 ions	
with	 the	 bacterial	 enzymes	 (Albert	 et al.,	 1953).	
8	 HQ	 complexation	with	 sulfanilamide	 enhances	
antimicrobial	 activity	 against	 Gram	 positive	
bacteria,	 the	 complex	 is	 more	 active	 than	 the	
individual	components	 taken	separately	(Shen	et 
al.,	 1999).	 Hydroxyquinoline	 based	 products	 are	
also	 active	 against	 yeasts	 (Candida albicans,	 C. 
tropicalis,	C. krusei	and	Torulopsis glabrata)	(Cancet	
RĂPUNTEAN	et al
Tab. 6.	The	average	value	of	the	inhibition	zones                                                                                                                      
No
Tested	strains
Products	with	HQ
(inhibition	areas/mm) Average	
(by	strains)1
HQ	-	Cu2+-	HAP
1
2
HQ	-	Cu2+ -	HAP2 3NHQ	-	Cu2+- HAP2
1 Staphylococcus	spp. 21.6 17.6 23.2 20.80
2 Micrococcus	spp.,	 25.2 19.6 27.6 24.13
3 Bacillus	spp. 15.6 14.0 18.0 15.86
4 Candida	spp. 24.0 20.4 26.4 23.60
5 Prototheca	spp, 27.6 20.8 30.0 26.13
Average	(by	products) 21.6 17.6 23.2 20.80
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et al.,	1987),	molds	(Aspergillus	spp.)	(Vanparia	et 
al.,	 2010;	 Al-Busaf	 et al.,	 2014),	 some	 parasites	
(Trichomonas)	 (Bergogne-Berezin	 et al.,	 1987)	
and	 agent	 of	 malaria	 (Plasmodium falciparum)	
(Adler	et	Scheibel,	1982;	Biswas,	2003).	Literature	
also	 mentions	 an	 antiviral	 effect	 (Rohde	 et al.,	
1976);	 (Kassem	 et al.,	 2012).	 Several	 chelating	
agents	have	been	 investigated	 for	 their	potential	
in	 the	 treatment	 of	 neurodegenerative	 diseases,	
a	series	of	8-hydroxyquinoline	analogs	have	been	
shown	to	have	great	potential	in	the	treatment	of	
such	 diseases,	 eg.	 Alzheimer’s,	 Parkinson’s	 and	
multiple	sclerosis	(Budimir,	2011),	the	anticancer	
(Ruiz-Azuara	 et al.,	 2010),	 antioxidant	 and	 anti-
inflammatory	 (Kim	et al.,	 2005)	and	antidiabetic	
effects	(Prachayasittikul	et al.,	2013).	The	products	
have	 found	application	 in	veterinary	medicine	 in	
the	treatment	of	otitis	in	dogs	and	cats	(Maestrone	
et al.,	 1979),	 or	 some	 digital	 papilloma	 in	 cattle	
(Britt	et al.,	1996).	
We	 believe	 that	 the	 results	 of	 the	
research	 resumed	 in	 this	 paper	 confirm	 the	
antimicrobial	 ability	 of	 tested	 products	 based	
on	 hydroxyquinoline	 and	 cupric	 derivatives	 in	
combination	 with	 hydroxyapatite.	 It	 has	 been	
demonstrated	 that	 the	 antimicrobial	 spectrum	
is	broad,	 intense	 and	bactericidal	 against	 strains	
of	 Staphylococcus,	 Micrococcus,	 Bacillus,	 but	
is	 even	 more	 intense	 over	 the	 genus	 Candida 
and	 Prototheca. The	 addition	 of	 hydroxyapatite	
increases	 the	 activity	 of	 these	 preparations,	
ensuring	 a	 better	 dispersion	 and	 persistence	 of	
the	products.	 
CONCLUSIONS
Products	 based	 on	 hydroxyquinoline	 and	
cupric	 derivatives	 deposited	 on	 hydroxyapatite,	
showed	 an	 intense	 antimicrobial	 activity	
against	 Gram	 positive	 bacteria	 (Staphylococcus,	
Micrococcus,	Bacillus),	yeast	(Candida),	unicellular	
algae	 (Prototheca)	 and	 lower	 activity	 against	
Gram-negative	bacteria	(Escherichia,	Salmonella).
Heavily	 inhibitory	 effect	 against	 all	 tested	
microorganisms	was	 recorded	 for	 the	 product	 3	
(NHQ-Cu2+-HAP
2
),	followed	by	the	product	1	(HQ-
Cu2+-HAP
1
),	 and	 product	 2	 (HQ-Cu2+-HAP
2
),	 the	
effect	being	bactericidal,	algicidal	and	fungicidal.	
Such	 products,	 prepared	 in	 the	 form	 of	
suspensions,	 may	 have	 practical	 application	 in	
the	 prevention	 and	 treatment	 of	 skin	 or	 hooves	
disorders,	when	isolated	microbiota	is	sensitive	to	
hydroxyquinoline	compounds.
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